Three researchers at the German Cancer Research Center (DKFZ) have each been awarded a Starting Grant from the European Research Council (ERC) this year. Daniel Kirschenbaum, Lena Kutscher, and Michael Scherer impressed the ERC with their innovative research approaches to fundamental questions in cancer medicine. With the funding, they plan to investigate why certain brain tumors occur more frequently in boys than in girls, how brain tumors suppress the immune system, and which epigenetic characteristics make cancer cells resistant to drugs.

The lab at our end-of-semester field day

The rhombic lip (RL) gives rise to all cerebellar glutamatergic cell types, including unipolar brush cells (UBCs). Disruptions to UBC development can lead to the neurodevelopmental disorder Dandy-Walk...

Summary: This Editorial offers an honest look at impact factor trends in developmental biology, explains how Development serves its community, and makes the case that sustaining developmental biology ...

Innovative Preclinical Models for Pediatric Cancer Research Cancer in children represents ∼3% of the global incidence of cancer. Pediatric cancer exerts an outsized impact: beyond the physical and emo...

Estonia, a hub of innovation and cutting-edge research, offers a vibrant ecosystem for postdoctoral researchers.

Summary: This Special Article provides a comprehensive overview of the methods, applications and considerations for the generation of cerebellar organoids.

YouTube video by The Late Show with Stephen Colbert

The German Research Foundation (DFG) is funding a new Emmy Noether project led by Jens Puschhof from the German Cancer Research Center (DKFZ). With this project, the junior researcher aims to decipher...

Paracetamol medicines can be used in pregnancy, in accordance with official recommendations